Tim-3 as a signalling receptor expressed by leukaemia cells and potential target for highly specific drug delivery
Leukaemia is a blood/bone marrow cancer caused by malignant immature hematopoietic precursors, and quickly becomes a systematic malignancy. The most severe type of leukaemia that has the highest number of lethal outcomes is Acute Myeloid Leukaemia (AML) where malignant cells escape host immune surve...
Main Author: | Bernardo Goncalves Oliveira Silva, Isabel |
---|---|
Other Authors: | Sumbayev, Vadim ; Gibbs, Bernhard |
Published: |
University of Kent
2017
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.739458 |
Similar Items
-
Polyamines and their potential exploitation in drug delivery
by: Travis, Natalie Gail
Published: (1998) -
Wireless capsule endoscope for targeted drug delivery
by: Woods, Stephen
Published: (2016) -
Assessment of potential antibacterial drug targets
by: Diaz Saez, Laura
Published: (2016) -
The role of specific receptor domains in signal transduction by the VIP2 receptor
by: MacKenzie, Christopher J.
Published: (1998) -
Antioxidant pathways and human leukaemia chemotherapeutic sensitivity
by: Heasman, Sally-Anne
Published: (2013)